erythrosine has been researched along with Heart Failure in 7 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Zhou, X | 1 |
Ding, G | 1 |
Fang, Q | 1 |
Guo, J | 1 |
Yang, L | 2 |
Wang, P | 1 |
Fu, SZ | 1 |
Li, A | 1 |
Xia, J | 2 |
Yu, J | 1 |
Ma, M | 1 |
Hu, Z | 1 |
Huang, L | 1 |
Liu, R | 1 |
Jiang, C | 1 |
Li, S | 1 |
Yu, M | 1 |
Xu, X | 1 |
Zhao, Y | 1 |
Hu, Q | 1 |
Xing, W | 1 |
Zhao, Z | 1 |
Fawzy, MS | 1 |
Ashour, H | 1 |
Shafie, AAA | 1 |
Dahman, NBH | 1 |
Fares, AM | 1 |
Antar, S | 1 |
Elnoby, AS | 1 |
Fouad, FM | 1 |
Devine, LD | 1 |
Gallagher, AM | 1 |
Briggs, S | 1 |
Hill, AJ | 1 |
Stopyra, W | 1 |
Alacamli, G | 1 |
Kaderli, ST | 1 |
Edebali, S | 1 |
Alacamli, OG | 1 |
Sul, S | 1 |
Canbek, TD | 1 |
Karalezli, A | 1 |
Stoicescu, EA | 1 |
Cherecheanu, AP | 1 |
Bostan, M | 1 |
Pîrvulescu, R | 1 |
Tiu, C | 1 |
Bujor, I | 1 |
Popa-Cherecheanu, A | 1 |
Balogun, MM | 1 |
Fashola, MB | 1 |
Shi, X | 1 |
Yu, X | 1 |
Duan, X | 1 |
Vandestienne, M | 1 |
Braik, R | 1 |
Lavillegrand, JR | 1 |
Hariri, G | 1 |
Demailly, Z | 1 |
Ben Hamouda, N | 1 |
Tamion, F | 1 |
Clavier, T | 1 |
Ait-Oufella, H | 1 |
Bampidis, V | 1 |
Azimonti, G | 1 |
Bastos, ML | 1 |
Christensen, H | 1 |
Durjava, M | 1 |
Kouba, M | 1 |
López-Alonso, M | 1 |
López Puente, S | 1 |
Marcon, F | 1 |
Mayo, B | 1 |
Pechová, A | 1 |
Petkova, M | 1 |
Ramos, F | 1 |
Sanz, Y | 1 |
Villa, RE | 1 |
Woutersen, R | 1 |
Brantom, P | 1 |
Chesson, A | 1 |
Westendorf, J | 1 |
Manini, P | 1 |
Dusemund, B | 1 |
Bickel Haase, T | 1 |
Naumann-Gola, S | 1 |
Ortner, E | 1 |
Zorn, H | 1 |
Schweiggert-Weisz, U | 1 |
Yang, N | 1 |
Gao, J | 1 |
Han, Y | 1 |
Zhang, L | 1 |
Furusawa, S | 1 |
Ikeda, M | 1 |
Ide, T | 1 |
Kanamura, T | 1 |
Miyamoto, HD | 1 |
Abe, K | 1 |
Ishimaru, K | 1 |
Watanabe, M | 1 |
Tsutsui, Y | 1 |
Miyake, R | 1 |
Fujita, S | 1 |
Tohyama, T | 1 |
Matsushima, S | 1 |
Baba, Y | 1 |
Tsutsui, H | 1 |
Dani, S | 1 |
Kumar, R | 1 |
Sharma, H | 1 |
Choudhary, RJ | 1 |
Goyal, N | 1 |
Kaur, P | 1 |
Pandit, R | 1 |
Pang, Y | 1 |
Bjornsson, R | 1 |
Chung, HR | 1 |
Miller, JE | 1 |
Suh, JD | 1 |
Margolis, G | 1 |
Hamuda, N | 1 |
Kobo, O | 1 |
Elbaz Greener, G | 1 |
Amir, O | 1 |
Homoud, M | 1 |
Madias, C | 1 |
Heist, EK | 1 |
Ruskin, JN | 1 |
Kazatsker, M | 1 |
Roguin, A | 1 |
Leshem, E | 1 |
Rozen, G | 1 |
Biasibetti, M | 1 |
Rojas, DB | 1 |
Hentschke, VS | 1 |
Moura, DJ | 1 |
Karsten, M | 1 |
Wannmacher, CM | 1 |
Saffi, J | 1 |
Dal Lago, P | 1 |
Schillinger, W | 1 |
Teucher, N | 1 |
Sossalla, S | 1 |
Kettlewell, S | 1 |
Werner, C | 1 |
Raddatz, D | 1 |
Elgner, A | 1 |
Tenderich, G | 1 |
Pieske, B | 1 |
Ramadori, G | 1 |
Schöndube, FA | 1 |
Kögler, H | 1 |
Kockskämper, J | 1 |
Maier, LS | 1 |
Schwörer, H | 1 |
Smith, GL | 1 |
Hasenfuss, G | 1 |
Steen, M | 1 |
Reidenberg, MM | 1 |
Affrime, M | 1 |
Dietzel, L | 1 |
Trautvetter, E | 1 |
von Recum, A | 1 |
Poirson, JP | 1 |
Werner, J | 1 |
Gorbachenkov, AA | 1 |
Batrachenko, IP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure[NCT00699361] | Phase 3 | 0 participants (Actual) | Interventional | 2008-08-31 | Withdrawn (stopped due to Study withdrawn for financial issues) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for erythrosine and Heart Failure
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
1 trial available for erythrosine and Heart Failure
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
6 other studies available for erythrosine and Heart Failure
Article | Year |
---|---|
The influence of low-level laser therapy on parameters of oxidative stress and DNA damage on muscle and plasma in rats with heart failure.
Topics: Animals; Antioxidants; DNA Damage; Fluoresceins; Glutathione Peroxidase; Heart Failure; Hemodynamics | 2014 |
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actin Cytoskeleton; Aniline Compounds; Animals; Anti-Ulcer | 2007 |
[Mercury poisoning caused by topical treatment of burns with merbromine (mercurochrome)].
Topics: Administration, Topical; Adult; Anuria; Burns; Fluoresceins; Heart Failure; Humans; Male; Merbromin; | 1983 |
Influence of disease on binding of drugs to plasma proteins.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; C | 1973 |
[Arm-lip-time in healthy dogs and dogs with heart diseases].
Topics: Animals; Blood Circulation Time; Dog Diseases; Dogs; Female; Fluoresceins; Heart Failure; Male | 1972 |
[Fluorescent angiography of the fundus oculi in patients with chronic circulatory insufficiency].
Topics: Adult; Angiography; Blood Circulation; Blood Flow Velocity; Cardiac Output; Constriction; Dye Diluti | 1971 |